Correvio Pharma Corp. (CORV)

Correvio Pharma Corp. (CORV $0.56)
- $0.56 Cap: $37M
- View CORV Profile
- View Questions on CORV

{tplLang.businessdescription | toLang tLang}

{ profileData.description }

{tplLang.details | toLang tLang}

{tplLang.ceo | toLang tLang}

{profileData.profile.details.ceo}

{tplLang.employees | toLang tLang}

{profileData.profile.details.employees | numeraljs '0,0'}

{tplLang.issuetype | toLang tLang}

{profileData.profile.details.issuetype | asIssueType}

{tplLang.industryclassifications | toLang tLang}

{tplLang.sector | toLang tLang}

{profileData.profile.classification.sector}

{tplLang.industry | toLang tLang}

{profileData.profile.classification.industry}

{tplLang.toolname| toLang tLang}

There is no {tplLang.toolname| toLang tLang} currently available for {data.symbolstring}.

Correvio Pharma Corp. (CORV $0.56)
- $0.56 Cap: $37M
- View CORV Profile
- View Questions on CORV

Q: The symbol has recently changed to CORM. What explains the recent growth in the share price? What is your assessment of the company? Thank you.

Read Answer Asked by Kurt W on June 14, 2018

Correvio Pharma Corp. (CORV $0.56)
- $0.56 Cap: $37M
- View CORV Profile
- View Questions on CORV

Q: Today, Cardiome jumped 8% in a down market based on receiving approval from Health Canada to market Brinavess and seem to have had a solid Q1 with Aggrastat. New product commercialization and launches are scheduled for next month and seem to have momentum. Can I have your assessment? Thank you for your support.

Marty

Read Answer Asked by Martin on May 18, 2017

IMV Inc. (IMV $1.12)
- $1.12 Cap: $13M
- View IMV Profile
- View Questions on IMV
Correvio Pharma Corp. (CORV $0.56)
- $0.56 Cap: $37M
- View CORV Profile
- View Questions on CORV

Q: hi guys.

I'm looking at Immunovaccine and Cardiome Pharma for small speculative plays. Can you give me any insight into these small caps?

Best
Linda

Read Answer Asked by linda on June 02, 2016